Member Info for HereforHemo

JHFH you are of course correct, perhaps I choose the wrong words. Be assured there is nothing I said that required an RNS. LTH’s know of the situation with CDX, anyone can work out when the next PQ run is due and as for II’s buying in most know it’s over 5p, which should be achieved within the month. With that I’ll be quiet and leave people to make their own decisions. Have a good weekend all.

I posted earlier saying I believed this was a once in a lifetime opportunity and I’m pleased to say I now have permission from Hemogenyx to update you all on the following:

* CDX is progressing well and Hemogenyx are working with one of the leading global pharmaceutical companies in the world to take it forward to IND.
* CAR-T is also progressing well and PQ3 results will be announced within the next 10 trading days with IND following shortly after. It’s important to note that if no questions are raised by the FDA in 28-30 days Hemogenyx immediately became a clinical company.
* CBR The absolute jewel in the crown, and why Vlad is so excited! At present Hemogenyx are testing CBR on multiple viruses, one of which is Covid. This includes ALL variants including the latest strain from China. With vaccines being nearly 70% less effective it is quite possible Hemogenyx will be first to market with a cure. Vlad is VERY bullish on this becoming a real paradigm shift in the world of treatment for viral diseases. In fact Hemogenyx believe CBR will become the Microsoft of the pharmaceutical world.
I am told large investors are buying, the biggest of pharmaceutical companies are interested in getting involved in progressing CBR and Institutional Investors are on the sidelines waiting for the opportunity to buy in. How do you put a value on the above? Certainly I’ve set a new target this year and that’s between 50p and £1. Not without risk and a lot of work to do, but I’m holding ALL my shares for a long long time. GLA

https://twitter.com/gavinfi79738737/status/1613862985717399552?s=20&t=h2J19LRS-FwPbyklt9pMdg

Mick glad you got involved. You ain’t seen nothing yet!

dhub after being massacred last year it’s hard to criticise people taking profits. However for me personally this is a once in a lifetime opportunity so I have very sticky fingers lol. Each to their own my friend.

Product potential x volume = BOOM

Pleased to see a fellow investor has excellent taste in Champagne. With the recent rise I’d recommend the ‘88 vintage or with two, possibly three excellent RNS’s due in the space of a month, might be worth waiting for the ‘66. GLA

People should bear in mind we’ve had none of the news we were expecting this quarter yet. Despite the recent rise we’re not even close to fair market value yet. Buckle in, gonna be a very exciting ride.

Personally I think charts are totally irrelevant for small caps. Each to their own but I only see this going higher as it’s still completely undervalued. That’s my opinion anyway.

HEMO CAR-T. Interesting stats.
•major growth expected 2023.
•multiple collaborations, partnerships and M&A activity.
•patent protection important.
•majority of revenue in North America.
•hospitals driving revenue, HEMO working with Penn Hospital.

https://www.yahoo.com/now/cellular-immunotherapy-car-t-cell-110300295.html

Waiting Many thanks. That’s what I love about this BB, lots of informative posts by very knowledgeable posters.

Mick No problem. Personally I’d try to do it before CAR-T PQ3 results are announced, which should be successful and will be the last step before their IND submission. Not certain but I’d expect them sometime during the next 12 trading days. Good luck.

Mick around £6m in the bank. Enough to progress CAR-T through phase1/2 clinical trials and do proof of concept for CBR. Possible $4m grant for CBR. Decision 21/3.

Let’s all just keep calm guys. Do not ruminate, only look forward. Enjoy the ride as you’d be lucky to get one of these opportunities every two years. Well in my experience anyway lol.

FFS Micky you are a matter of weeks away from turning things around and being in profit. Please don’t turn into Mr India so close to transformational news. Relax mate lol.

Vlad feels the same lol

https://twitter.com/vmsandler/status/1613047619772903424?s=20&t=NC-yCT7se8vHWuGreLsrWg

I said a while back people would regret selling at 1.2 and 1.33 and although I understand people wanting to take profit (understandable after the worst bear market since 2008), I can tell you now people will regret cashing HEMO in at 2.33 as well. So why do I think that? I would think that any well researched investor would know, the final test results of HEMO CAR-T testing, PQ3 will be released within the next 13 trading days. Within 10 trading days of that HEMO’s IND application will be submitted to the FDA, and a maximum of 20 trading days after that Hemogenyx will become a clinical company. This is just one of three viable product candidates, and we can expect positive updates on both their CDX bi-specific antibody and the extremely exciting CBR platform during this period. For me personally, if I look two months ahead, I’m anticipating an average rise of 25% for each week between now and then. So a Mcap of anywhere between £60-80m in March. So by all means take profit, nothing wrong with that but although it’s only my opinion, do yourself a big favour. leave something in as I really think you’ll kick yourself if you don’t.

HEMO broker..

https://twitter.com/justamantrading/status/1612716175598784512?s=20&t=2ia6YJlkUfvF1pDuKWy4Fw

Good point, I just looked at the location rather than the high level contagious diseases require. My excitement got the better of me lol

A few things in answer to your question. Firstly Hemogenyx are working on CBR at a US government owned laboratory, I would guess maybe Wadsworth in New York State. Secondly they may be getting a $4m grant in March for the bio defense program and thirdly it’s well known they already have an unnamed partner to progress CBR with. So many different avenues for this to progress either internally or externally. I’m sure we’ll know more details soon.